{"name":"Abingworth","permalink":"abingworth-management","crunchbase_url":"http://www.crunchbase.com/financial-organization/abingworth-management","homepage_url":"http://www.abingworth.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"+ 44 (0)20 7534 1500","description":"Life sciences & healthcare","email_address":"info@abingworth.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Sat Jan 24 04:49:05 UTC 2009","updated_at":"Wed May 20 22:27:19 UTC 2009","overview":"<p>Abingworth is an international investment group dedicated exclusively to the life sciences and healthcare sectors. We invest across all stages of company development including early and late-stage venture financing, growth equity and public companies. </p>\n\n<p>Founded in 1973, Abingworth has a lengthy track record of building market leading companies. Our specialist team of over 20 professionals has a broad range of skills, including scientific and business expertise as well as investment banking, recruitment and legal knowledge. These resources are made available to portfolio companies. Abingworth has funds under management of over $1.25 billion and offices in London, Menlo Park (California) and Boston. </p>","image":{"available_sizes":[[[150,49],"assets/images/resized/0003/6134/36134v2-max-150x150.jpg"],[[221,73],"assets/images/resized/0003/6134/36134v2-max-250x250.jpg"],[[221,73],"assets/images/resized/0003/6134/36134v2-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":"3000 Sand Hill Road ","address2":"Bldg. 4, Suite 135 ","zip_code":"94025 ","city":"Menlo Park ","state_code":"CA","country_code":"USA","latitude":37.4182724,"longitude":-122.2249367}],"relationships":[],"investments":[{"funding_round":{"round_code":"debt_round","source_url":"http://venturebeat.com/2008/06/24/broncus-technologies-lines-up-venture-debt-financing-for-emphysema-treatment/","source_description":"Broncus Technologies lines up venture debt financing for emphysema treatment","raised_amount":null,"raised_currency_code":"USD","funded_year":1000,"funded_month":1,"funded_day":1,"company":{"name":"Broncus Technologies, Inc. ","permalink":"broncus-technologies-inc","image":{"available_sizes":[[[150,29],"assets/images/resized/0003/4691/34691v1-max-150x150.png"],[[242,47],"assets/images/resized/0003/4691/34691v1-max-250x250.png"],[[242,47],"assets/images/resized/0003/4691/34691v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/synosia-raises-29m-phase-ii-testing/2009-01-07","source_description":"Synosia raises $29M for Phase II testing","raised_amount":29000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":1,"funded_day":null,"company":{"name":"Synosia Therapeutics","permalink":"synosia-therapeutics","image":{"available_sizes":[[[150,49],"assets/images/resized/0004/3264/43264v1-max-150x150.png"],[[217,71],"assets/images/resized/0004/3264/43264v1-max-250x250.png"],[[217,71],"assets/images/resized/0004/3264/43264v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/clovis-oncology-inc-series-a-145m/","source_description":"Clovis Oncology (Boulder, CO) an entity focused on licensing or acquiring rights to oncology compounds in all stages of clinical development","raised_amount":145000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":5,"funded_day":26,"company":{"name":"Clovis Oncology","permalink":"clovis-oncology","image":{"available_sizes":[[[150,39],"assets/images/resized/0017/8043/178043v1-max-150x150.png"],[[250,65],"assets/images/resized/0017/8043/178043v1-max-250x250.png"],[[262,69],"assets/images/resized/0017/8043/178043v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Capital Report Index","raised_amount":24500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":23,"company":{"name":"Chroma Therapeutics","permalink":"chroma-therapeutics","image":{"available_sizes":[[[150,52],"assets/images/resized/0005/2160/52160v1-max-150x150.jpg"],[[250,87],"assets/images/resized/0005/2160/52160v1-max-250x250.jpg"],[[257,90],"assets/images/resized/0005/2160/52160v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/intellikine-inc-series-b-51m/","source_description":"Intellikine, Inc.: Series B $51M","raised_amount":51000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":7,"funded_day":22,"company":{"name":"Intellikine","permalink":"intellikine","image":{"available_sizes":[[[150,29],"assets/images/resized/0005/4526/54526v1-max-150x150.jpg"],[[234,46],"assets/images/resized/0005/4526/54526v1-max-250x250.jpg"],[[234,46],"assets/images/resized/0005/4526/54526v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://deals.venturebeat.com/2007/01/05/neurological-co-synosis-raises-325m/","source_description":"Neurological co. Synosis raises $32.5M","raised_amount":32500000,"raised_currency_code":"USD","funded_year":2007,"funded_month":1,"funded_day":5,"company":{"name":"Synosia Therapeutics","permalink":"synosia-therapeutics","image":{"available_sizes":[[[150,49],"assets/images/resized/0004/3264/43264v1-max-150x150.png"],[[217,71],"assets/images/resized/0004/3264/43264v1-max-250x250.png"],[[217,71],"assets/images/resized/0004/3264/43264v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.sec.gov/Archives/edgar/data/1375151/000137515109000006/xslFormDX01/primary_doc.xml","source_description":"SEC D","raised_amount":35957968,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":5,"company":{"name":"Zogenix","permalink":"zogenix","image":{"available_sizes":[[[100,23],"assets/images/resized/0006/0696/60696v1-max-150x150.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-250x250.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/primeradx-inc-series-c-20m/","source_description":"PrimeraDx, Inc.: Series C $20M","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":30,"company":{"name":"PrimeraDx","permalink":"primeradx","image":{"available_sizes":[[[150,40],"assets/images/resized/0006/4292/64292v3-max-150x150.png"],[[250,66],"assets/images/resized/0006/4292/64292v3-max-250x250.png"],[[450,120],"assets/images/resized/0006/4292/64292v3-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/oxagen-rounds-26-7m-vc/2009-11-24?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_description":"Oxagen rounds up $26.7M in VC","raised_amount":26700000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":24,"company":{"name":"Oxagen","permalink":"oxagen","image":{"available_sizes":[[[150,45],"assets/images/resized/0006/7578/67578v1-max-150x150.png"],[[152,46],"assets/images/resized/0006/7578/67578v1-max-250x250.png"],[[152,46],"assets/images/resized/0006/7578/67578v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.zogenix.com/index.php/news/zogenix-raises-18-million-in-preferred-stock-financing/","source_description":"Zogenix Raises $18 Million in Preferred Stock Financing","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":1,"funded_day":9,"company":{"name":"Zogenix","permalink":"zogenix","image":{"available_sizes":[[[100,23],"assets/images/resized/0006/0696/60696v1-max-150x150.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-250x250.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.syntaxin.com/biopharma-news-article.php?id=39","source_description":"Syntaxin Raises $32M to Advance Development of Novel Drug Pipeline","raised_amount":32000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":31,"company":{"name":"Syntaxin","permalink":"syntaxin","image":{"available_sizes":[[[150,64],"assets/images/resized/0008/0047/80047v1-max-150x150.jpg"],[[182,78],"assets/images/resized/0008/0047/80047v1-max-250x250.jpg"],[[182,78],"assets/images/resized/0008/0047/80047v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.chromatherapeutics.com/press-releases/Press-Release-7.pdf","source_description":"CHROMA THERAPEUTICS COMPLETES $53 MILLION SERIES C FINANCING","raised_amount":53000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":4,"funded_day":3,"company":{"name":"Chroma Therapeutics","permalink":"chroma-therapeutics","image":{"available_sizes":[[[150,52],"assets/images/resized/0005/2160/52160v1-max-150x150.jpg"],[[250,87],"assets/images/resized/0005/2160/52160v1-max-250x250.jpg"],[[257,90],"assets/images/resized/0005/2160/52160v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.allbusiness.com/banking-finance/financial-markets-investing-funds/5047060-1.html","source_description":"Adiana, Inc. Reports Completion of $23 Million Financing.","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":8,"funded_day":25,"company":{"name":"Adiana","permalink":"adiana","image":{"available_sizes":[[[150,60],"assets/images/resized/0006/0308/60308v1-max-150x150.png"],[[214,87],"assets/images/resized/0006/0308/60308v1-max-250x250.png"],[[214,87],"assets/images/resized/0006/0308/60308v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"","source_description":"Cap Funding Report","raised_amount":10390000,"raised_currency_code":"USD","funded_year":2005,"funded_month":11,"funded_day":14,"company":{"name":"Syntaxin","permalink":"syntaxin","image":{"available_sizes":[[[150,64],"assets/images/resized/0008/0047/80047v1-max-150x150.jpg"],[[182,78],"assets/images/resized/0008/0047/80047v1-max-250x250.jpg"],[[182,78],"assets/images/resized/0008/0047/80047v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32&aid=DJFVW00020101006e6a7001jl&r=Rss&s=DJFVW","source_description":"Public IS Pharma Takes In $5.7M From Abingworth In Private Placement  ","raised_amount":5700000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":7,"company":{"name":"IS Pharma","permalink":"is-pharma","image":{"available_sizes":[[[150,60],"assets/images/resized/0010/4655/104655v1-max-150x150.png"],[[250,100],"assets/images/resized/0010/4655/104655v1-max-250x250.png"],[[330,132],"assets/images/resized/0010/4655/104655v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32&aid=DJFVW00020101006e6a60008d&r=Rss&s=DJFVW","source_description":"Alta Partners Leads $30M Series C For Pathwork Diagnostics  ","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":6,"company":{"name":"Pathwork Diagnostics","permalink":"pathwork-diagnostics","image":{"available_sizes":[[[150,47],"assets/images/resized/0008/4707/84707v1-max-150x150.jpg"],[[211,67],"assets/images/resized/0008/4707/84707v1-max-250x250.jpg"],[[211,67],"assets/images/resized/0008/4707/84707v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/vcs-inject-29m-syntaxin-115m-ceregene/2010-11-11?utm_medium=rss&utm_source=rss","source_description":"VCs inject $29M into Syntaxin, $11.5M into Ceregene","raised_amount":29000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":11,"funded_day":11,"company":{"name":"Syntaxin","permalink":"syntaxin","image":{"available_sizes":[[[150,64],"assets/images/resized/0008/0047/80047v1-max-150x150.jpg"],[[182,78],"assets/images/resized/0008/0047/80047v1-max-250x250.jpg"],[[182,78],"assets/images/resized/0008/0047/80047v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"https://www.mdon-line.com/mdonline/press/mdol.release.05.18.2011.asp","source_description":"MD On-Line Announces Equity Investment from Abingworth ","raised_amount":null,"raised_currency_code":"USD","funded_year":2011,"funded_month":5,"funded_day":18,"company":{"name":"MD On-Line","permalink":"md-on-line","image":{"available_sizes":[[[150,23],"assets/images/resized/0013/5656/135656v1-max-150x150.png"],[[250,38],"assets/images/resized/0013/5656/135656v1-max-250x250.png"],[[325,50],"assets/images/resized/0013/5656/135656v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2011/09/valeritas-raises-150m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Valeritas Raises $150m in Series C financing.","raised_amount":150000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":9,"funded_day":12,"company":{"name":"Valeritas","permalink":"valeritas","image":{"available_sizes":[[[143,52],"assets/images/resized/0009/2151/92151v2-max-150x150.jpg"],[[143,52],"assets/images/resized/0009/2151/92151v2-max-250x250.jpg"],[[143,52],"assets/images/resized/0009/2151/92151v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.reuters.com/article/2012/01/25/idUS63683+25-Jan-2012+BW20120125","source_description":"Prosensa Raises €23 Million in New Equity Financing Led by New Enterprise Associates","raised_amount":23000000,"raised_currency_code":"EUR","funded_year":2012,"funded_month":1,"funded_day":25,"company":{"name":"Prosensa","permalink":"prosensa","image":{"available_sizes":[[[150,52],"assets/images/resized/0004/8560/48560v1-max-150x150.png"],[[250,86],"assets/images/resized/0004/8560/48560v1-max-250x250.png"],[[311,108],"assets/images/resized/0004/8560/48560v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.sonitusmedical.com/sonitus/news/series-d-financing.cfm","source_description":"Sonitus Medical Closes $25 Million Series D Round of Venture Capital Financing","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":5,"funded_day":15,"company":{"name":"Sonitus Medical","permalink":"sonitus-medical","image":{"available_sizes":[[[150,37],"assets/images/resized/0019/0166/190166v1-max-150x150.png"],[[250,63],"assets/images/resized/0019/0166/190166v1-max-250x250.png"],[[250,63],"assets/images/resized/0019/0166/190166v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2012/07/chiasma-closes-38-5m-series-equity-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Chiasma Closes $38.5M Series D Equity Financing","raised_amount":38500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":7,"funded_day":23,"company":{"name":"Chiasma","permalink":"chiasma","image":{"available_sizes":[[[150,43],"assets/images/resized/0008/4257/84257v1-max-150x150.jpg"],[[250,72],"assets/images/resized/0008/4257/84257v1-max-250x250.jpg"],[[259,75],"assets/images/resized/0008/4257/84257v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}